The Most Common Long-Term Side Effects and How They Evolve Nausea remains the most frequently reported side effect, affecting 2040% of patients at some point during treatment
This combination of effectiveness and safety is accelerating their adoption across both diabetic and non-diabetic obese populations
Current evidence suggests that melatonin does not cause physical dependence in the same way as traditional sleep medications
The STEP-HFpEF-DM trial confirmed the benefits of once-weekly semaglutide also in obese patients affected by type 2 diabetes
'I lost 79lbs with GLP-1 after needing a wheelchair to make my flight on time' Suzy Britain, 62, weighed 208lbs and a size 18 at her heaviest and was traveling to visit her sister in New York when a walk to her connecting gate in Philadelphia turned into an exhausting ordeal A woman who was "so fat" she needed a wheelchair to make her flight on time lost 79lbs with GLP-1 medication
When preventable harm occurs, questions may arise about whether appropriate warnings were provided and whether manufacturers or other responsible parties can be held accountable